Acetaminophen is used to reduce fever and relieve mild to moderate pain, such as headaches, muscle aches, and cold symptoms.[2] Tylenol is currently approved and in use across 167 indications[4].[1]
Tylenol is one of 2441 small molecule programs targeting HIV infection. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Patents
Pipeline
Competition
2828 competitors in Breast Cancer
Tylenol
Halaven
Prolia
DATROWAY
Lupron
Nubain
Vfend
Fentanyl Citrate
Neoadjuvant Treatment
Perflutren Lipid Microsphere
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jan 1, 1982
ACEPHEN
NDA NDA018060
Jan 1, 1982
NEOPAP
NDA NDA016401
Jan 1, 1982
TYLENOL
NDA NDA017756
Sep 12, 1983
ACETAMINOPHEN
NDA NDA018337
Mar 7, 1986
INJECTAPAP
NDA NDA017785
Jun 8, 1994
TYLENOL
NDA NDA019872
Nov 2, 2010
OFIRMEV
NDA NDA022450
Oct 28, 2015
ACETAMINOPHEN
NDA NDA204767
Jan 15, 2021
ACETAMINOPHEN
NDA NDA206610
Feb 18, 2021
ACETAMINOPHEN
NDA NDA204957
Jun 3, 2022
ACETAMINOPHEN
NDA NDA206968
Sources
Details
Patent Cliff
Nov 13, 2028
Earliest patent expiration — generic entry possible after this date